Pearson, Thomas A.
University of Florida · University of Florida Health Science Center
19 papers on CoChat
Most cited papers
- Verified
Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation
Lipoproteins and Cardiovascular HealthInflammatory Biomarkers in Disease Prognosis
Cited by 6,401
- Verified
Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke
Acute Ischemic Stroke ManagementCardiovascular Health and Risk Factors
Cited by 1,306
- Verified
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
Gaziano, J. M., Brotons, C., Coppolecchia, R., Cricelli, C., Darius, H., Gorelick, P. B., Howard, G., Pearson, T. A., Rothwell, P. M., Ruilope, L. M., et al. (2018) · The Lancet
Antiplatelet Therapy and Cardiovascular DiseasesLipoproteins and Cardiovascular Health
Cited by 883
- Verified
AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update
Smith, S. C., Blair, S. N., Bonow, R. O., Brass, L. M., Cerqueira, M. D., Dracup, K., Fuster, V., Gotto, A., Grundy, S. M., Miller, N. H., et al. (2001) · Journal of the American College of Cardiology
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 691
- Verified · note
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update: A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology
Smith, S. C., Blair, S. N., Bonow, R. O., Brass, L. M., Cerqueira, M. D., Dracup, K., Fuster, V., Gotto, A., Grundy, S. M., Miller, N. H., et al. (2001) · Circulation
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 661
- Verified · note
Primary Prevention of Coronary Heart Disease: Guidance From Framingham: A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction
Grundy, S. M., Balady, G. J., Criqui, M. H., Fletcher, G., Greenland, P., Hiratzka, L. F., Houston-Miller, N., Kris-Etherton, P., Krumholz, H. M., LaRosa, J., et al. (1998) · Circulation
Health Promotion and Cardiovascular PreventionCardiovascular Health and Risk Factors
Cited by 609
- Verified
Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group Recommendations
Davidson, M. H., Maki, K. C., Pearson, T. A., Pasternak, R. C., Deedwania, P. C., McKenney, J. M., Fonarow, G. C., Maron, D. J., Ansell, B. J., Clark, L. T., et al. (2005) · The American Journal of Cardiology
Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular Prevention
Cited by 270
- Verified
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial
Topol, E. J., Bousser, M.-G., Fox, K. A., Creager, M. A., Despres, J.-P., Easton, J. D., Hamm, C. W., Montalescot, G., Steg, P. G., Pearson, T. A., et al. (2010) · The Lancet
Pharmacology and Obesity TreatmentCannabis and Cannabinoid Research
Cited by 266
- Verified
Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)
Bernhardt, J., Churilov, L., Ellery, F., Collier, J., Chamberlain, J., Langhorne, P., Lindley, R. I., Moodie, M., Dewey, H., Thrift, A. G., et al. (2016) · Neurology
Stroke Rehabilitation and RecoveryAcute Ischemic Stroke Management
Cited by 221
- Verified
Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study
Miller, M., Seidler, A., Moalemi, A., & Pearson, T. A. (1998) · Journal of the American College of Cardiology
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 193
- Verified
Coffee consumption and the incidence of coronary heart disease.
LaCroix, A. Z., Mead, L. A., Liang, K.-Y., Thomas, C. B., & Pearson, T. A. (1986) · New England Journal of Medicine
Coffee research and impactsAlcohol Consumption and Health Effects
Cited by 183
- Verified
Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states
Berglund, L., Lefevre, M., Ginsberg, H. N., Kris-Etherton, P. M., Elmer, P. J., Stewart, P. W., Ershow, A., Pearson, T. A., Dennis, B. H., Roheim, P. S., et al. (2007) · The American Journal of Clinical Nutrition
Fatty Acid Research and HealthDiet, Metabolism, and Disease
Cited by 172
- Verified
Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography
Herrington, D. M., Gordon, G. B., Achuff, S. C., Trejo, J. F., Weisman, H. F., Kwiterovich, P. O., & Pearson, T. A. (1990) · Journal of the American College of Cardiology
Hormonal and reproductive studiesAdrenal Hormones and Disorders
Cited by 147
- Verified
Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol.
Miller, M., Seidler, A., Kwiterovich, P. O., & Pearson, T. A. (1992) · Circulation
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 131
- Verified
Task force 8. Organization of preventive cardiology service
Pearson, T. A., McBride, P. E., Miller, N. H., & Smith, S. C. (1996) · Journal of the American College of Cardiology
Health Promotion and Cardiovascular PreventionBlood Pressure and Hypertension Studies
Cited by 110
- Verified
Longitudinal changes in dehydroepiandrosterone concentrations in men and women
Nafziger, A. N., Bowlin, S. J., Jenkins, P. L., & Pearson, T. A. (1998) · Journal of Laboratory and Clinical Medicine
Hormonal and reproductive studiesAdrenal Hormones and Disorders
Cited by 82
- Verified
Importance of risk factors in the angiographic progression of coronary artery disease
Raichlen, J. S., Healy, B., Achuff, S. C., & Pearson, T. A. (1986) · The American Journal of Cardiology
Cardiovascular Health and Risk FactorsCardiac Imaging and Diagnostics
Cited by 47
- Verified
Coffee intake and coronary heart disease
Klag, M. J., Mead, L. A., Lacroix, A. Z., Wang, N.-Y., Coresh, J., Liang, K.-Y., Pearson, T. A., & Levine, D. M. (1994) · Annals of Epidemiology
Coffee research and impactsNutritional Studies and Diet
Cited by 47
- Verified
Training Medical Students in Community Health: A Novel Required Fourth-Year Clerkship at the University of Rochester
McIntosh, S., Block, R. C., Kapsak, G., & Pearson, T. A. (2008) · Academic Medicine
Health and Medical EducationInnovations in Medical Education
Cited by 45
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free